New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival?

Anti-Cancer Drugs

Volumn 22, Issue 7, 2011, Pages 596-606

  Thariat, Juliette ^a   Bolle, Stephanie ^c   Demizu, Yusuke ^e   Marcy, Pierre Yves ^a   Hu, Yi ^b   Santini, Jose ^a   Bourhis, Jean ^d   Pommier, Pascal ^b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE LÉON BÉRARD   (France)

^c Hop Pitie Salpetriere   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e HYOGO ION BEAM MEDICAL CENTER   (Japan)

Author keywords

advances; atlas; carbon ion therapy; CyberKnife; head and neck cancer; image guided radiation therapy; intensity modulated radiation therapy; local control; proton therapy; survival; TomoTherapy; toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL;

ALOPECIA; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COBALT THERAPY; COMPUTER ASSISTED RADIOTHERAPY; CYBERKNIFE; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CARCINOMA; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; IRRADIATION; LARYNX CARCINOMA; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; OPTIC NERVE DISEASE; OROPHARYNX CANCER; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTON THERAPY; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; REVIEW; SALIVARY GLAND; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TOMOTHERAPY; VISUAL IMPAIRMENT; XEROSTOMIA;

CARBON; CLINICAL TRIALS AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; PROTONS; QUALITY OF LIFE; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL;

EID: 79960462119     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328340fd2b     Document Type: Review

References (73)

1. Yang ES, Murphy BM, Chung CH, Netterville JL, Burkey BB, Gilbert J, et al. Evolution of clinical trials in head and neck cancer. Crit Rev Oncol Hematol 2009; 71:29-42.
2. Shaikh M, Burmeister J, Joiner M, Pandya S, Zhao B, Liu Q. Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical TomoTherapy. Med Phys 2010; 37:762-770.
3. Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 2007; 25:4096-4103. (Pubitemid 47492954)
4. Nutting C, A'Hern R, Rogers MS, Sydenham MA, Adab F, Harrington K, et al. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J Clin Oncol 2009; 27 (Suppl. abstr LBA6006):18s.
5. Mendenhall WM. Mandibular osteoradionecrosis. J Clin Oncol 2004; 22:4867-4868. (Pubitemid 46638608)
6. Bhide SA, Harrington KJ, Nutting CM. Otological toxicity after post¬operative radiotherapy for parotid tumours. Clin Oncol (R Coll Radiol) 2007; 19:77-82. (Pubitemid 46044072)
7. Hammerlid E, Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 2001; 84:149-156. (Pubitemid 32113438)
8. Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, et al. Initial clinical experience with helical TomoTherapy for head and neck cancer. Head Neck 2009; 31:1571-1578.
9. Farrag A, Voordeckers M, Tournel K, De Coninck P, Storme G. Pattern of failure after helical TomoTherapy in head and neck cancer. Strahlenther Onkol 2010.
10. Kodaira T,Tomita N, Tachibana H, Nakamura T, Nakahara R, Inokuchi H, et al. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical TomoTherapy. Int J Radiat Oncol Biol Phys 2009; 73:1129-1134.
11. Moon SH, Jung YS, Ryu JS, Choi SW, Park JY, Yun T, et al. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010. [Epub ahead of print].
12. Sheng K, Molloy JA, Larner JM, Read PW. A dosimetric comparison of non-coplanar IMRT versus helical TomoTherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol 2007; 82:174-178. (Pubitemid 46275139)
13. Laskar S, Bahl G, Muckaden M, Pai SK, Gupta T, Banavali S, et al. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72:728-736.
14. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25:4873-4879. (Pubitemid 350220416)
15. Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001; 61:275-280. (Pubitemid 33127232)
16. Popovtzer A, Cao Y, Feng FY, Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol 2009; 93:510-515.
17. Gluck I, Feng FY, Lyden T, Haxer M, Worden F, Chepeha DB, et al. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 77:727-733.
18. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy versus conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006; 66:981-991. (Pubitemid 44633504)
19. Tao Y, Daly-Schveitzer N, Lusinchi A, Bourhis J. Advances in radiotherapy of head and neck cancers. Curr Opin Oncol 2010; 22:194-199.
20. Kung SW, Wu VW, Kam MK, Leung SF, Yu BK, Ngai DY, et al. Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2010.
21. Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 2008; 118:635-639. (Pubitemid 351496757)
22. Hodge CW, Bentzen SM, Wong G, Palazzi-Churas KL, Wiederholt PA, Gondi V, et al. Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys 2007; 69:1032-1041. (Pubitemid 47625846)
23. Rades D, Fehlauer F, Wroblesky J, Albers D, Schild SE, Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol 2007; 43:535-543. (Pubitemid 46860347)
24. Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009; 74:1-8.
25. Dirix P, Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010; 11:85-91.
26. Chen AM, Farwell DG, Luu Q, Chen LM, Vijayakumar S, Purdy JA. Misses and near-misses after postoperative radiation therapy for head and neck cancer: comparison of IMRT and non-IMRT techniques in the CT-simulation era. Head Neck 2010. [Epub ahead of print]
27. Guerrero Urbano MT, Clark CH, Kong C, Miles E, Dearnaley DP, Harrington KJ, et al. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol (R Coll Radiol) 2007; 19:604-613. (Pubitemid 47308656)
28. Orlandi RR, Marple BF. Developing, regulating, and ethically evaluating new technologies in otolaryngology-head and neck surgery. Otolaryngol Clin North Am 2009; 42:739-745. vii.
29. Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 2007; 85:36-41. (Pubitemid 47570062)
30. Caudell JJ, Burnett OL III, Schaner PE, Bonner JA, Duan J. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys 2010; 77:462-467.
31. Ciura K, McBurney M, Nguyen B, Pham M, Rebueno N, Fuller CD, et al. Effect of brain stem and dorsal vagus complex dosimetry on nausea and vomiting in head and neck intensity-modulated radiation therapy. Med Dosim 2010. [Epub ahead of print]
32. Rosenthal DI, Chambers MS, Fuller CD, Rebueno NC, Garcia J, Kies MS, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 72:747-755.
33. Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP, et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009; 92:111-117.
34. Krayenbuehl J, Davis JB, Ciernik IF. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer. Radiother Oncol 2006; 81:151-157. (Pubitemid 44708369)
35. Doornaert P, Verbakel WF, Bieker M, Slotman BJ, Senan S. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010.
36. Oliver M, Gagne I, Popescu C, Ansbacher W, Beckham WA. Analysis of RapidArc optimization strategies using objective function values and dose-volume histograms. J Appl Clin Med Phys 2010; 11:3114.
37. Korreman S, Medin J, Kjaer-Kristoffersen F. Dosimetric verification of RapidArc treatment delivery. Acta Oncol 2009; 48:185-191.
38. Beavis AW. Is TomoTherapy the future of IMRT? Br J Radiol 2004; 77:285-295. (Pubitemid 38579112)
39. Fiorino C, Dell'Oca I, Pierelli A, Broggi S, De Martin E, Di Muzio N, et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical TomoTherapy. Radiother Oncol 2006; 78:276-282.
40. Lee TK, Rosen II, Gibbons JP, Fields RS, Hogstrom KR. Helical TomoTherapy for parotid gland tumors. Int J Radiat Oncol Biol Phys 2008; 70:883-891.
41. Murthy V, Master Z, Gupta T, Ghosh-Laskar S, Budrukkar A, Phurailatpam R, et al. Helical TomoTherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT. J Cancer Res Ther 2010; 6:194-198.
42. Van Vulpen M, Field C, Raaijmakers CP, Parliament MB, Terhaard CH, MacKenzie MA, et al. Comparing step-and-shoot IMRT with dynamic helical TomoTherapy IMRT plans for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 62:1535-1539. (Pubitemid 40982080)
43. Yang C, Liu T, Jennelle RL, Ryu JK, Vijayakumar S, Purdy JA, et al. Utility of megavoltage fan-beam CT for treatment planning in a head-and-neck cancer patient with extensive dental fillings undergoing helical TomoTherapy. Med Dosim 2010; 35:108-114.
44. Voordeckers M, Everaert H, Tournel K, Verellen D, Baron I, Van Esch G, et al. Longitudinal assessment of parotid function in patients receiving TomoTherapy for head-and-neck cancer. Strahlenther Onkol 2008; 184:400-405.
45. Thariat J, Li G, Angellier G, Marchal S, Palamini G, Rucka G, et al. Current indications and ongoing clinical trials with CyberKnife stereotactic radiotherapy in France in 2009. Bull Cancer 2009; 96:853-864.
46. Truong MT, Grillone G, Tschoe C, Chin L, Kachnic LA, Jalisi S. Emerging applications of stereotactic radiotherapy in head and neck cancer. Neurosurg Focus 2009; 27:E11.
47. Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S, et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 2009; 75:1493-1500.
48. Heron DE. Stereotactic body radiation therapy for recurrent head & neck cancers: rethinking nonoperative salvage strategies. Future Oncol 2009; 5:1321-1325.
49. Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, et al. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh Experience. Am J Clin Oncol 2009; 33:286-293.
50. Zhao B, Yang Y, Li T, Li X, Heron DE, Huq MS. Image-guided respiratory-gated lung stereotactic body radiotherapy: which target definition is optimal? Med Phys 2009; 36:2248-2257.
51. Nomoto S, Shioyama Y, Ohga S, Nonoshita T, Ohnishi K, Atsumi K, et al. Preliminary results of radiation therapy for locally advanced or recurrent adenoid cystic carcinomas of the head and neck using combined conventional radiation therapy and hypofractionated inverse planned stereotactic radiation therapy. Fukuoka Igaku Zasshi 2009; 100:59-66.
52. Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 2009; 74:1047-1053.
53. Zhang X, Penagaricano J, Moros EG, Corry PM, Yan Y, Ratanatharathorn V. Dosimetric comparison of helical TomoTherapy and linac-IMRT treatment plans for head and neck cancer patients. Med Dosim 2009. [Epub ahead of print]
54. Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R, et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 2006; 5:529-535. (Pubitemid 44606275)
55. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL, et al. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2009; 74:1348-1355.
56. Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, et al. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 77:1411-1419.
57. Kawaguchi K, Sato K, Horie A, Iketani S, Yamada H, Nakatani Y, et al. Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol 2010; 5:51.
58. Lartigau E, Comet B, Faivre-Pierret M, Coche-Dequeant B, Degardin M, Lefebvre J, et al. CyberKnife ± Cetuximab as salvage treatment for locally recurrent head and neck cancer: a phase I/II study in 50 patients. CK Users' Meeting 2010.
59. Inoue HK, Suzuki Y, Takahashi T, Sakurai H, Nakano T, Nozaki A, et al. Retreatment of recurrent pharyngeal and laryngeal cancers with cyberknife radiosurgery. CyberKnife Users' Meeting 2010.
60. Cengiz M, Ozyigit G, Yazici G, Dogan A, Yildiz F, Gürkaynak M, et al. Salvage stereotactic body radiotherapy for locally recurrent head and neck carcinomas. CK Users' Meeting 2010.
61. Suit H, DeLaney T, Goldberg S, Paganetti H, Clasie B, Gerweck L, et al. Proton versus carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010; 95:3-22.
62. Goitein M. Trials and tribulations in charged particle radiotherapy. Radiother Oncol 2010; 95:23-31.
63. Slater JD, Yonemoto LT, Mantik DW, Bush DA, Preston W, Grove RI, et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys 2005; 62:494-500. (Pubitemid 40704467)
64. Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, Tsujii H. Carbon ion radiotherapy for skull base chordoma. Skull Base 2009; 19:219-224.
65. Schulz-Ertner D, Nikoghosyan A, Didinger B, Munter M, Jakel O, Karger CP, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005; 104:338-344. (Pubitemid 40993261)
66. Pommier P, Liebsch NJ, Deschler DG, Lin DT, McIntyre JF, Barker FG II, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132:1242-1249. (Pubitemid 44800140)
67. Resto VA, McKenna MJ, Deschler DG. Pectoralis major flap in composite lateral skull base defect reconstruction. Arch Otolaryngol Head Neck Surg 2007; 133:490-494. (Pubitemid 46799787)
68. Fitzek MM, Thornton AF, Varvares M, Ancukiewicz M, McIntyre J, Adams J, et al. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 2002; 94:2623-2634. (Pubitemid 34478077)
69. Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 2007; 68:758-762. (Pubitemid 46818736)
70. Mizoe JE, Tsujii H, Kamada T, Matsuoka Y, Tsuji H, Osaka Y, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 60:358-364. (Pubitemid 39233452)
71. Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2009; 74:15-20.
72. Chan AW, Liebsch NJ. Proton radiation therapy for head and neck cancer. J Surg Oncol 2008; 97:697-700. (Pubitemid 351812971)
73. Demizu Y, Murakami M, Miyawaki D, Niwa Y, Akagi T, Sasaki R, et al. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys 2009; 75:1487-1492.